DoubleLine ETF Adviser’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Sell
8,779
-1,023
-10% -$1.05M 4.35% 1
2026
Q1
$9.02M Buy
+9,802
New +$9.94M 3.43% 4

Other funds holding LLY

DoubleLine ETF Adviser's LLY Position: Q2 2026 in Review

DoubleLine ETF Adviser reduced its Eli Lilly (LLY) stake by 10% in Q2 2026, selling an estimated $1.05M and leaving 8,779 shares worth $10.5M. The position accounts for 4.35% of the portfolio, ranked #1.

DoubleLine ETF Adviser first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • DoubleLine ETF Adviser held 8,779 shares of Eli Lilly worth $10.5M as of Q2 2026.
  • DoubleLine ETF Adviser sold 1,023 Eli Lilly shares in Q2 2026, an estimated $1.05M.
  • Eli Lilly made up 4.35% of DoubleLine ETF Adviser's portfolio in Q2 2026, its #1 holding.
  • DoubleLine ETF Adviser first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.